Knowledge Exchange is running in developer mode.

Frequency and severity of hypoglycemia under conditions of increased hypoglycemic risk with insulin efsitora alfa versus insulin glargine treatment in participants with type 2 diabetes 2024

Assessing time in range with postprandial glucose-focused titration of ultra rapid lispro (URLi) in people with type 1 diabetes 2023

Correlation between time in range and HbA1c in people with type 2 diabetes on basal insulin: post hoc analysis of the SWITCH PRO study 2023

Renal complications and duration of diabetes: an international comparison in persons with type 1 diabetes 2021

InRange: comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design 2020

Efficacy and safety of taspoglutide versus sitagliptin for type 2 diabetes mellitus (T-emerge 4 trial) 2012